Red Flags to Look Out for When Dispensing Controlled Substances

Video

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to controlled substance prescriptions.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to controlled substance prescriptions.

This video was recorded at the 2015 NCPA Annual Convention.

Recent Videos
Image credit: Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Related Content
Pregnant woman -- Image credit: Syda Productions | stock.adobe.com

Analysis Findings Indicate Relationship Between Maternal Asthma and Risk for Autism Spectrum Disorders

Gillian McGovern, Assistant Editor
July 24th 2024
Article
Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

July 12th 2024
Podcast
Image Credit: © Africa Studio - stock.adobe.com

FDA Approves IncobotulinumtoxinA for the Simultaneous Treatment of Upper Facial Lines

Alexandra Gerlach, Associate Editor
July 24th 2024
Article
Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

June 27th 2024
Podcast
Man and woman hiking in Infected ticks forest with warning sign. Risk of tick-borne and lyme disease - Image credit: 24K-Production | stock.adobe.com

During Summer Months, Counsel Patients on Preventing Lyme Disease

Sofiya Volynsky, PharmD;Atosa Nazemi, PharmD;Melissa Russo, PharmD;Bruce Roberts, PharmD;Mandy Hoysan, PharmD
July 24th 2024
Article
Medicine law concept. Judges gavel with pills - Image credit: Iren Moroz | stock.adobe.com

The Ethics and Economics of California’s End of Life Option Act

Sawyer Y. Mustopoh;Joseph L. Fink III, JD, BSPharm, DSc (Hon), FAPhA
July 24th 2024
Article